AZO GANTRISIN
LOE ApproachingNDAORALTABLET
Approved
Aug 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AZO GANTRISIN is an oral tablet small-molecule combination product approved by Roche in 1990 for urinary tract infections and related indications. The product combines phenazopyridine (a urinary analgesic) with sulfamethoxazole (a sulfonamide antibiotic) to provide symptomatic relief and antimicrobial therapy. It is administered orally and represents a legacy fixed-dose combination with established clinical utility in primary care and urology settings.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30), indicating reduced team investment and focus on managed decline rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AZO GANTRISIN offers limited career growth; the product is in managed decline with zero linked jobs in the current market. This assignment is typically a transition role, suitable for professionals managing legacy products or transitioning toward other therapeutic areas.
Brand Manager (legacy portfolio)Regulatory Affairs Specialist
Worked on AZO GANTRISIN at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.